Add to Calendar 5/5/2022 8:30:00 AM 5/5/2022 8:30:00 PM 2022 State of Possible Conference MassBio's annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry, key insights from the past year, and building a better future for patients around the world. This year's conference will explore the theme "The Massachusetts BioPharma Ecosystem in the Post- Covid Era."

Join MassBio and more than 500 attendees for a day of networking, keynotes, and panel discussions from some of the most inspiring voices in the industry, culminating in a reception celebrating the life sciences community. This is our most popular event so you will want to reserve your spot early. Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Session Title Start Time End Time
So Your Biotech is Public, Now What?
Across 2020 and 2021, 149 biotech companies went public nationally at offerings over $50 million. These companies continued a trend of more companies going public through an IPO earlier in their life-cycle – the median time from founding to IPO has gone from 10 years in 2013 to only 4 years in 2021. Going public is a major milestone, but much lies ahead. This panel of experts will discuss life after after an IPO, especially during the current market downturn. 		5/5/2022 2:00 PM 5/5/2022 2:45 PM
Global Supply Chain Challenges, What does 2022 and Beyond Look Like?
Global supply chain disruptions are impacting every piece of the economy and the life sciences is no exception. From unavailability to longer lead times to significant price increases, life sciences companies are being forced to reckon with new levels of uncertainty that can impact business operations and business strategies. This panel will discuss how global supply chain disruptions have impacted their organization, how they have reacted, and how they are planning for the future. 		5/5/2022 2:45 PM 5/5/2022 3:30 PM
Beyond the CEO Pledge, Where are we Now?
In this panel we will hear directly from member companies who signed MassBio’s CEO Pledge for a More Equitable and Inclusive Life Sciences Industry about their approach to meeting the pledge’s six commitments around improving DEI at their organization. The wide-ranging discussion will cover areas such as leadership and executive culture, inclusive company culture, recruitment & retention, and supplier diversity. 		5/5/2022 3:45 PM 5/5/2022 4:30 PM

Brought to you by